Cardiotrophin-1 and TNF-α circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals

Cytokine

Volumn 50, Issue 3, 2010, Pages 245-247

  Limongelli, Giuseppe ^a   Calabrò, Paolo ^a   Maddaloni, Valeria ^a   Russo, Antonio ^a   Masarone, Daniele ^a   D'Aponte, Antonello ^a   Roselli, Teo ^a   Bonauro, Rosa ^a   D'Alessandro, Raffaella ^a   D'Andrea, Antonello ^a   Pacileo, Giuseppe ^a   Limongelli, Francesco Mario ^a   Calabro', Raffaele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Athlete's heart; Cardiopulmonary stress test; Cardiotrophin 1; TNF

Indexed keywords

CARDIOTROPHIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATHLETE; BLOOD SAMPLING; BODY SURFACE; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE VOLUME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXYGEN CONSUMPTION; OXYGEN SATURATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REST;

ADULT; ATHLETES; CYTOKINES; EXERCISE TEST; HEALTH; HEART; HUMANS; LUNG; MALE; REST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77952544188     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.12.007     Document Type: Article

References (11)

1. Suzuki K., Nakaji S., Yamada M., Totsuka M., Sato K., Sugawara K. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002, 8:6-48.
2. Zaldivar F., Wang-Rodriguez J., Nemet D., Schwindt C., Galassetti P., Mills P.J., et al. Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes. J Appl Physiol 2006, 100:1124-1133.
3. Petersen A.M., Pedersen B.K. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharamcol 2006, 10:43-51.
4. Gokhale R., Chandrashekara S., Vasanthakumar K.C. Cytokine response to strenuous exercise in athletes and non-athletes-an adaptive response. Cytokine 2007, 40:123-127.
5. Ikonomidis I., Stamatelopoulos K., Lekakis J., Vamvakou G.D., Kremastinos D.T. Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 2008, 199:3-11.
6. Yndestad A., Damås J.K., Øie E., Ueland T., Gullestad L., Aukrust P. Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007, 9:236-241.
7. Pelliccia A., Maron B.J., Spataro A., Proschan M.A., Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained athletes. N Engl J Med 1991, 324:295-301.
8. Limongelli G., Verrengia M., Pacileo G., et al. Left ventricular hypertrophy in Caucasian master athletes: differences with hypertension and hypertrophic cardiomyopathy. Int J Cardiol 2006, 111:113-119.
9. Bozkurt B., Kribbs S.B., Clubb F.J., Michael L.H., Didenko V.V., Hornsby P.J., et al. Pathophysiologically relevant concentrations of tumor necrosis factor-a promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998, 97:1382-1391.
10. Calabrò P., Limongelli G., Riegler L., Maddaloni V., Palmieri R., Golia E., et al. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol 2009, 46:142-148.
11. Smith L.L. Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress?. Med Sci Sports Exerc 2000, 32:317-331.